MedImmune LLC:企業の戦略的SWOT分析

◆英語タイトル:MedImmune LLC - Strategic SWOT Analysis Review
◆商品コード:DATA904C15788
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

MedImmune LLC – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

MedImmune LLC (MedImmune), a subsidiary of AstraZeneca Plc, is a biotechnology company. It focuses on the research, development, manufacture, and marketing of small molecules and biologics to address some of the major medical needs. The company develops therapeutic proteins, monoclonal antibodies and other next-generation molecules targeting various diseases. MedImmune undertakes research in the areas of cancer treatment; respiratory; inflammation and autoimmune; and cardiovascular disorders and metabolic diseases. It also develops vaccines for the prevention of infectious diseases. The company operates three R&D centers in Gaithersburg, Maryland; Cambridge, the UK; and Mountain View, California. MedImmune is headquartered in Gaithersburg, Maryland, the US.

MedImmune LLC Key Recent Developments

Feb 14,2019 “MedImmune” brand to be retired as biologics integrate into AstraZeneca’s new R&D structure
Dec 04,2018 CELLINK announces collaboration with MedImmune to utilize CELLINKs’ 3D-Bioprinting technology for drug discovery
Sep 14,2018 US FDA Approves LUMOXITI™ (moxetumomab pasudotox-tdfk) for Certain Patients with Relapsed or Refractory Hairy Cell Leukemia[Newswire : Healthcare-BW]
Aug 20,2018 AstraZeneca is advancing understanding of cardio-renal-metabolic interconnectivity with new evidence at ESC 2018
Jun 18,2018 N4 Pharma: Update on Nuvec

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
MedImmune LLC – Key Facts
MedImmune LLC – Key Employees
MedImmune LLC – Key Employee Biographies
MedImmune LLC – Major Products and Services
MedImmune LLC – History
MedImmune LLC – Company Statement
MedImmune LLC – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
MedImmune LLC – Business Description
MedImmune LLC – SWOT Analysis
SWOT Analysis – Overview
MedImmune LLC – Strengths
MedImmune LLC – Weaknesses
MedImmune LLC – Opportunities
MedImmune LLC – Threats
MedImmune LLC – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
MedImmune LLC, Recent Deals Summary
Section 4 – Company’s Recent Developments
Feb 14, 2019: “MedImmune” brand to be retired as biologics integrate into AstraZeneca’s new R&D structure
Dec 04, 2018: CELLINK announces collaboration with MedImmune to utilize CELLINKs’ 3D-Bioprinting technology for drug discovery
Sep 14, 2018: US FDA Approves LUMOXITI™ (moxetumomab pasudotox-tdfk) for Certain Patients with Relapsed or Refractory Hairy Cell Leukemia[Newswire : Healthcare-BW]
Aug 20, 2018: AstraZeneca is advancing understanding of cardio-renal-metabolic interconnectivity with new evidence at ESC 2018
Jun 18, 2018: N4 Pharma: Update on Nuvec
Apr 04, 2018: AstraZeneca’s early and late-stage oncology portfolio showcased at AACR annual meeting and ELCC
Feb 28, 2018: MedImmune to create stand-alone company for early-stage inflammation and autoimmunity biologics
Jan 01, 2018: New Bio-Incubator and Life-Science Accelerator Capability Launches at the Babraham Research Campus
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
MedImmune LLC, Key Facts
MedImmune LLC, Key Employees
MedImmune LLC, Key Employee Biographies
MedImmune LLC, Major Products and Services
MedImmune LLC, History
MedImmune LLC, Other Locations
MedImmune LLC, Subsidiaries
MedImmune LLC, Key Competitors
MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
MedImmune LLC, Recent Deals Summary

List of Figures
MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
MedImmune LLC, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[MedImmune LLC:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Brammer Plc (BRAM):企業概要、財務及び戦略的SWOT分析
    Summary Brammer plc (Brammer) is an industrial maintenance, repair and overhaul product distributor. The company distributes various industrial products to industries. Its products include bearings and seals, mechanical power transmission, electronical power transmission, fluid power and tools. Bram …
  • Druzhba Staklarski Zavodi AD Sofia:企業の戦略・SWOT・財務分析
    SummaryDruzhba Staklarski Zavodi AD Sofia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the c …
  • Eiger BioPharmaceuticals, Inc.(製薬・医療分野):企業M&A動向
    Summary Eiger BioPharmaceuticals, Inc. (Eiger) is a biopharmaceutical company. The company discovers and develops new antiviral agents to treat hepatitis virus infection. Its product candidates include EBP921, EBP994, and Hepatititis Delta Virus (HDV) Replication and Prenylation. The company’s HDV l …
  • Underwriters Laboratories Inc.:企業のM&A・事業提携・投資動向
    Underwriters Laboratories Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Underwriters Laboratories Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • JA Solar Holdings Co Ltd (JASO):企業の財務・戦略的SWOT分析
    JA Solar Holdings Co Ltd (JASO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Altus Group Limited:企業のM&A・提携・投資分析
    Altus Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Altus Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Cox Communications, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cox Communications, Inc. Merger …
  • Salmat Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Salmat Limited Mergers and Acqu …
  • Eureka Forbes Limited:企業の戦略的SWOT分析
    Eureka Forbes Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Medivir AB (MVIR B):企業概要、財務及び戦略的SWOT分析
    Summary Medivir AB (Medivir) is a bio-pharmaceutical company. The company concentrates on the research and development of drugs for the treatment of infectious diseases. It provides drugs for the disorders such as hepatitis C, mouth ulcers, zinc deficiency, psychiatry, HIV, bone disorders, and neuro …
  • General Biologicals Corp (4117):企業のM&A・提携動向(医療機器分野)
    Summary General Biologicals Corp (GBC) is a medical device company that offers diagnostic equipment. The company develops and manufactures in-vitro diagnostic devices. It provides liver inspection tools such as test reagents and equipment. GBC’s products include real-time PCR kits and automated syst …
  • The Stanley Works:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' The Stanley Works Mergers and A …
  • Hokko Chemical Industry Co., Ltd. (4992):企業財務及び戦略的SWOT分析
    Summary Hokko Chemical Industry Co., Ltd. (Hokko Chemical) develops and markets crop protection products and fine chemical products. The company’s products include organophosphines, fragrance raw materials, intermediates for agrochemicals and pharmaceutical chemicals, specialty styrenes and organome …
  • WellCare Health Plans Inc (WCG):製薬・医療:M&Aディール及び事業提携情報
    Summary WellCare Health Plans Inc (WellCare) is a managed care services provider which focuses on providing government-sponsored managed care services to families, children, seniors and individuals with complex medical needs. The company offers Medicaid health plans, Medicare Advantage (MA) coordina …
  • Sika AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sika AG Mergers and Acquisition …
  • Analytik Jena AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Analytik Jena AG Mergers and Ac …
  • LinkedIn Corp:企業の戦略的SWOT分析
    LinkedIn Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Daepyung Co., Ltd.:企業の戦略・SWOT・財務分析
    SummaryDaepyung Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Brammer plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Brammer plc Mergers and Acquisi …
  • Joint Stock Commercial Bank for Foreign Trade of Vietnam (VCB):企業の財務・戦略的SWOT分析
    Joint Stock Commercial Bank for Foreign Trade of Vietnam (VCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆